Clinical trial
Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
NCT00418067 is registered in ClinicalTrials.gov with Seung-Jung Park as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
- Lead sponsor
- Seung-Jung Park
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- January 31, 2009
- Enrollment
- 2,645 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.